Euda Health Holdings Stock Price To Earnings To Growth
| EUDA Stock | 3.05 0.02 0.66% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess EUDA Health's long-term financial health and intrinsic value.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. EUDA Health Holdings Company Price To Earnings To Growth Analysis
EUDA Health's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, EUDA Health Holdings has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and about the same as Health Care (which currently averages 0.0) industry. The price to earnings to growth for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Headlines Timeline Now
Headlines TimelineStay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
| All Next | Launch Module |
EUDA Fundamentals
| Return On Asset | -1.07 | ||||
| Operating Margin | (0.47) % | ||||
| Current Valuation | 113.62 M | ||||
| Shares Outstanding | 37.16 M | ||||
| Shares Owned By Insiders | 50.47 % | ||||
| Shares Owned By Institutions | 2.24 % | ||||
| Number Of Shares Shorted | 9.93 K | ||||
| Price To Sales | 28.07 X | ||||
| Revenue | 4.01 M | ||||
| Gross Profit | 762.15 K | ||||
| EBITDA | (17.42 M) | ||||
| Net Income | (17.6 M) | ||||
| Total Debt | 1.27 M | ||||
| Book Value Per Share | (0.07) X | ||||
| Cash Flow From Operations | (2.03 M) | ||||
| Short Ratio | 0.10 X | ||||
| Earnings Per Share | (0.52) X | ||||
| Target Price | 6.0 | ||||
| Number Of Employees | 117 | ||||
| Beta | -0.067 | ||||
| Market Capitalization | 112.58 M | ||||
| Total Asset | 1.73 M | ||||
| Retained Earnings | (50.1 M) | ||||
| Working Capital | (3.38 M) | ||||
| Net Asset | 1.73 M |
About EUDA Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze EUDA Health Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EUDA Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EUDA Health Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether EUDA Health Holdings is a strong investment it is important to analyze EUDA Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact EUDA Health's future performance. For an informed investment choice regarding EUDA Stock, refer to the following important reports:Check out EUDA Health Piotroski F Score and EUDA Health Altman Z Score analysis. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Healthcare space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EUDA Health. If investors know EUDA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EUDA Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of EUDA Health Holdings is measured differently than its book value, which is the value of EUDA that is recorded on the company's balance sheet. Investors also form their own opinion of EUDA Health's value that differs from its market value or its book value, called intrinsic value, which is EUDA Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EUDA Health's market value can be influenced by many factors that don't directly affect EUDA Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EUDA Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if EUDA Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EUDA Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.